Stockreport

MaxCyte reports Q3 results [Seeking Alpha]

MaxCyte, Inc.  (MXCT) 
PDF MaxCyte reiterates 2025 revenue guidance for core business revenue and SPL Program-related revenue: Core Recommended For You More Trending News [Read more]